Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: Anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation

Transplant International

Volumn 13, Issue 5, 2000, Pages 363-371

  Duijvestijn, A M ^a   Derhaag, J G ^a   Van Breda Vriesman, P J C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Alloantibodies; Complement; Heart endothelial cells; MHC; Non MHC; Transplantation

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR DISEASE; VASCULAR LESION;

EID: 0033798916     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2000.tb01011.x     Document Type: Article

References (37)

1. Experimental graft arteriosclerosis
2. Interleukin 1(IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
3. The contribution of the terminal complement components to acute and hyperacute allograft rejection in the rat
4. Cytotoxic and enhancing properties of early gammaM alloantibodies elicited by first set renal allografts
5. Induced expression of endothelial-leucocyte adhesion molecules in human cardiac allografts
6. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor
7. IgG anti-endothelial cell autoantibodies from scleroderma patients induce leucocyte adhesion to human vascular endothelial cells in vitro
8. Interactions between endothelial cells and alloreactive T cells involved in allograft immunity
9. Renal allografts
10. Cellular and molecular mechanism of allograft rejection
11. Anti-endothelial antibodies after heart transplantation: The accelerating factor in transplant-associated coronary artery disease
12. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor
13. Heart EC respond heterogeneous on cytokine stimulation in ICAM-1 and VCAM-1, but not in MHC expression; A study with 3 rat heart endothelial cell (RHEC) lines
14. Production and characterization of spontaneous rat-heart endothelial cell lines
15. An in vitro model for studying the role of graft endothelial cells in rat heart allograft rejection: A study on the regulation and function of heart endothelial histocompatibility antigens and cell adhesion molecules
16. Effects of antibody reactivity to MHC and non-MHC alloantigens on graft endothelial cells in heart allograft rejection
17. Chronic renal allograft rejection: Selective involvement of the glomerular endothelium in humoral reactivity and intravascular coagulation
18. Chronic renal allograft rejection: The significance of non-MHC alloantigens
19. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
20. Anti cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients
21. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection
22. Tissue distribution of complement regulatory membrane proteins in rats
23. Renal transplant rejection. Transient immunodominance of HLA mismatches
24. Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies from rejected human renal allografts
25. Enhancement by the complement membrane attack complex of tumor necrosis factor-induced endothelial cell expression of e-selectin and ICAM-1
26. An endothelial growth factor from bovine hypothalamus: Identification and partial characterization
27. Endothelial activation and chronic allograft rejection
28. Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts
29. Complement contributes to the rejection of complete and class I major histocompatibility complex - Incompatible cardiac allografts
30. Coronary atherosclerosis in transplanted mouse hearts
31. Transient pertubation of endothelial intigrity induced by natural antibodies and complement
32. Complement mediated regulation of tissue factor activity in endothelium
33. Role of mobile passenger lymphocytes in the rejection of renal and cardiac allografts in the rat. A passenger lymphocyte mediated graft versus host reaction amplifies the host response
34. Rat monoclonal antibodies for complement mediated and cell mediated cytolysis
35. Characterization of anti-endothelial cell and anti-heart antibodies following heart transplantation
36. Up-regulation of lung vascular ICAM-1 in rats is complement dependent
37. Tissue antigens in tubulointerstitial and vascular rejection